Coegin Pharma AB (NGM:COEGIN)

Coegin Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.27	7.92	19.68	5.55	3.82	25.66
Cash & Short-Term Investments	9.27	7.92	19.68	5.55	3.82	25.66
Cash Growth	-40.47%	-59.74%	254.70%	45.39%	-85.13%	54.12%
Accounts Receivable	0.07	0.07	-	-	-	-
Other Receivables	0.61	0.51	0.99	0.64	3.13	4.64
Receivables	0.68	0.58	0.99	0.64	3.13	4.64
Prepaid Expenses	0.22	0.27	0.17	0.02	0.02	0.03
Other Current Assets	1.34	1.23	-0	-	-	-
Total Current Assets	11.5	10	20.84	6.21	6.97	30.33
Property, Plant & Equipment	0.19	0.11	0.15	0.3	0.49	0
Other Intangible Assets	2.46	3.18	6.05	8.92	11.79	-
Other Long-Term Assets	-	0.06	-	-	10	-
Total Assets	14.21	13.34	27.04	15.43	29.25	30.34

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.97	0.64	0.98	1.79	2	9.73
Accrued Expenses	0.79	2.59	0.66	2.66	1.71	0.22
Current Income Taxes Payable	0.02	-	-	-	0.18	-
Other Current Liabilities	0.46	5.37	0.15	4.24	4.34	0.31
Total Current Liabilities	2.24	8.6	1.78	8.68	8.23	10.26
Total Liabilities	2.24	8.6	1.78	8.68	8.23	10.26

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	14.3	12.44	12.44	4.7	35.33	27.57
Additional Paid-In Capital	146.4	136.2	136.2	101.6	94.76	66.38
Retained Earnings	-	-	-	-	-	-75.07
Comprehensive Income & Other	-148.73	-143.9	-123.38	-99.54	-109.08	1.2
Shareholders' Equity	11.97	4.74	25.26	6.75	21.01	20.07
Total Liabilities & Equity	14.21	13.34	27.04	15.43	29.25	30.34

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	9.27	7.92	19.68	5.55	3.82	25.66
Net Cash Growth	-40.47%	-59.74%	254.70%	45.39%	-85.13%	54.12%
Net Cash Per Share	0.37	0.32	1.04	0.60	0.56	4.32
Filing Date Shares Outstanding	28.59	24.88	24.88	9.39	6.94	6.94
Total Common Shares Outstanding	28.59	24.88	24.88	9.39	6.94	6.94
Working Capital	9.26	1.4	19.06	-2.47	-1.26	20.07
Book Value Per Share	0.42	0.19	1.02	0.72	3.03	2.89
Tangible Book Value	9.51	1.56	19.21	-2.17	9.22	20.07
Tangible Book Value Per Share	0.33	0.06	0.77	-0.23	1.33	2.89
Machinery	-	0.72	0.63	0.64	0.68	0.15

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error